Chicago Partners Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.27M Buy
37,801
+552
+1% +$63.7K 0.1% 192
2025
Q4
$4.03M Buy
37,249
+5,472
+17% +$514K 0.1% 183
2025
Q3
$2.77M Buy
31,777
+2,218
+8% +$183K 0.07% 229
2025
Q2
$2.48M Buy
29,559
+6,263
+27% +$498K 0.07% 227
2025
Q1
$1.84M Sell
23,296
-3,907
-14% -$365K 0.06% 249
2024
Q4
$2.72M Buy
27,203
+3,909
+17% +$403K 0.09% 184
2024
Q3
$2.48M Buy
23,294
+289
+1% +$34.3K 0.09% 186
2024
Q2
$2.65M Buy
23,005
+1,244
+6% +$160K 0.1% 169
2024
Q1
$2.76M Sell
21,761
-1,465
-6% -$181K 0.12% 153
2023
Q4
$2.76M Sell
23,226
-1,203
-5% -$125K 0.13% 145
2023
Q3
$2.52M Buy
24,429
+5,813
+31% +$627K 0.14% 142
2023
Q2
$1.97M Buy
18,616
+2,982
+19% +$339K 0.1% 190
2023
Q1
$1.81M Buy
15,634
+1,822
+13% +$197K 0.11% 188
2022
Q4
$1.46M Buy
13,812
+1,044
+8% +$107K 0.09% 210
2022
Q3
$1.28M Sell
12,768
-677
-5% -$60.4K 0.09% 202
2022
Q2
$1.2M Buy
13,445
+98
+0.7% +$8.69K 0.09% 203
2022
Q1
$1.23M Buy
13,347
+429
+3% +$33.8K 0.09% 185
2021
Q4
$988K Buy
12,918
+71
+0.6% +$5.66K 0.07% 221
2021
Q3
$1.08M Buy
12,847
+649
+5% +$49.4K 0.08% 212
2021
Q2
$942K Sell
12,198
-2,017
-14% -$150K 0.07% 228
2021
Q1
$1.05M Buy
14,215
+1,511
+12% +$111K 0.09% 194
2020
Q4
$982K Buy
12,704
+598
+5% +$45.7K 0.09% 179
2020
Q3
$889K Buy
12,106
+592
+5% +$46.4K 0.11% 153
2020
Q2
$867K Buy
11,514
+272
+2% +$20.5K 0.11% 146
2020
Q1
$895K Sell
11,242
-802
-7% -$63K 0.14% 122
2019
Q4
$1.05M Sell
12,044
-42
-0.3% -$3.45K 0.13% 122
2019
Q3
$952K Buy
12,086
+558
+5% +$44.7K 0.13% 116
2019
Q2
$893K Buy
11,528
+306
+3% +$23.4K 0.13% 120
2019
Q1
$784K Sell
11,222
-5,839
-34% -$437K 0.12% 128
2018
Q4
$1.21M Sell
17,061
-6,783
-28% -$479K 0.18% 102
2018
Q3
$1.63M Buy
23,844
+10,268
+76% +$654K 0.24% 73
2018
Q2
$786K Buy
13,576
+7,584
+127% +$428K 0.12% 131
2018
Q1
$311K Sell
5,992
-2,566
-30% -$139K 0.05% 210
2017
Q4
$460K Buy
8,558
+2,934
+52% +$163K 0.08% 172
2017
Q3
$344K Buy
5,624
+5,248
+1,396% +$318K 0.06% 201
2017
Q2
$23K Sell
376
-4,491
-92% -$273K 0.01% 497
2017
Q1
$295K Buy
4,867
+121
+3% +$7.34K 0.08% 150
2016
Q4
$267K Buy
4,746
+102
+2% +$5.97K 0.1% 146
2016
Q3
$277K Buy
4,644
+4,433
+2,101% +$259K 0.11% 143
2016
Q2
$12K Hold
211
0.01% 347
2016
Q1
$11K Hold
211
0.01% 337
2015
Q4
$11K Hold
211
0.01% 387
2015
Q3
$10K Hold
211
0.01% 333
2015
Q2
$11K Sell
211
-2
-0.9% -$112 0.01% 337
2015
Q1
$12K Sell
213
-55
-21% -$3.11K 0.01% 333
2014
Q4
$15K Buy
+268
New +$14.9K 0.01% 320

Other funds holding MRK

Chicago Partners Investment Group's MRK Position: Q1 2026 in Review

Chicago Partners Investment Group increased its Merck (MRK) stake by 1.5% in Q1 2026, buying an estimated $63.7K and bringing the position to 37,801 shares worth $4.27M. The position accounts for 0.1% of the portfolio, ranked #192.

Chicago Partners Investment Group first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Chicago Partners Investment Group held 37,801 shares of Merck worth $4.27M as of Q1 2026.
  • Chicago Partners Investment Group bought 552 Merck shares in Q1 2026, an estimated $63.7K.
  • Merck made up 0.1% of Chicago Partners Investment Group's portfolio in Q1 2026, its #192 holding.
  • Chicago Partners Investment Group first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.